Organogenesis Holdings Inc. Reports Fourth Quarter 2022 and Fiscal Year 2022 Financial Results; Introduces Fiscal Year 2023 Guidance
Go back to Organogenesis Holdings Inc. Reports Fourth Quarter 2022 and Fiscal Year 2022 Financial Results; Introduces Fiscal Year 2023 Guidance| (NASDAQ: ORGO) | Delayed: 2.43 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.43 | 52 Week High | $ | |||
| Open | $2.43 | 52 Week Low | $ | |||
| Day High | $2.43 | P/E | N/A | |||
| Day Low | $2.43 | EPS | $ | |||
| Volume | 80 | |||||

